Enterprise Therapeutics raised $37M Series B venture round, led by David Morris, MD.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
NovartisLEAD | Private | — |
Versant VenturesLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$78.7M
Top Valuation
-
Enterprise Therapeutics raised $37M in a Series B round.
The round was announced on 04/12/18.
The round was led by David Morris, MD, Alexander Mayweg.